Indication
To delay the onset of Stage 3 type 1 diabetes in adult and paediatric patients 8 years of age and older with Stage 2 type 1 diabetes
Medicine details
- Medicine name:
- teplizumab (Tzield)
- SMC ID:
- SMC2961
- Pharmaceutical company
- Sanofi
- BNF chapter
- Endocrine system
- Submission type
- Full